This is a rare genetic condition that affects how the body processes the amino acid glycine. It's caused by a problem with a specific system in the body's cells. This condition can lead to problems with brain function, muscle weakness, and other symptoms. It's not related to diabetes.
Every report comes from a Lived member, sent anonymously.
Have you tried Dextromethorphan for Nonketotic Hyperglycinemia?
Nonketotic hyperglycinemia (NKH), also called glycine encephalopathy, is a rare inherited metabolic disorder in which the body cannot break down glycine, an amino acid. Glycine is a building block of proteins and also acts as a chemical messenger in the brain and spinal cord. When a group of enzymes called the glycine cleavage system does not work, glycine builds up throughout the body, and the excess disrupts how the brain and nerves function. Despite the similar-sounding name, it has nothing to do with high blood sugar. Most babies with NKH become ill in the first days of life. They grow increasingly sleepy and hard to wake, feed poorly, are very floppy because of low muscle tone, and may have hiccups, seizures or pauses in breathing that can be life-threatening. Some children instead show signs between a few weeks and a few months of age, usually low muscle tone and slow development. Doctors describe two forms based on how a child ultimately does. In severe NKH, a child makes little or no developmental progress and has seizures that are very hard to control. In attenuated (milder) NKH, children make real but variable progress and have seizures that are treatable or absent. About 85 percent of babies who become ill as newborns have the severe form, while children whose symptoms begin after three months of age have the attenuated form.
NKH is caused by changes in genes that carry the instructions for the glycine cleavage system, most often one gene (about 80 percent of cases) and less often a second one. The amount of enzyme activity a child's gene changes leave largely determines severity: changes that eliminate the system's activity cause severe NKH, while changes that preserve some activity cause the attenuated form. Nothing a parent did during pregnancy causes it, and diet or illness do not trigger it. The condition is inherited in an autosomal recessive pattern, which means a child is affected only when both copies of the gene carry a change. Parents of an affected child are usually healthy carriers of one copy each. When both parents are carriers, each pregnancy has a 25 percent (1 in 4) chance of an affected child, a 50 percent chance of a child who is a carrier, and a 25 percent chance of a child who neither has the condition nor carries it. Whether a family's children have the severe or attenuated form tends to be the same among brothers and sisters.
NKH is usually suspected in a newborn who becomes very sleepy, floppy and seizure-prone without another explanation, such as infection or lack of oxygen at birth. Testing then measures glycine in the blood and in cerebrospinal fluid, the fluid around the brain and spinal cord, which is collected by a spinal tap. Glycine is high in both, and the key clue is how high the spinal fluid level is compared with the blood level, because that ratio separates NKH from other causes of raised glycine. Brain MRI (magnetic resonance imaging) and an EEG (a recording of the brain's electrical activity) often show characteristic patterns, such as a smaller-than-usual corpus callosum, the band of tissue connecting the two halves of the brain. Genetic testing confirms the diagnosis by finding changes in both copies of one of the responsible genes. MRI findings and the type of gene changes can also help doctors estimate whether a child is likely to have the severe or attenuated form, though early test results do not predict the outcome for every child. Once a family's gene changes are known, relatives can have carrier testing, and testing is possible during a future pregnancy or of embryos created through in vitro fertilization.
There is no treatment that cures NKH or changes its underlying course, so care aims to control symptoms, support development and protect comfort. The main medicine is sodium benzoate, which lowers the level of glycine in the blood. In severe NKH it can make a child more alert and seizures easier to manage, although it does not prevent the developmental delays, stiffness and hard-to-control epilepsy. It can irritate the stomach and esophagus, and doses are adjusted using regular blood tests. In the attenuated form, sodium benzoate is often combined with a medicine meant to calm brain receptors that excess glycine is thought to overstimulate, most commonly dextromethorphan (the ingredient used in many cough medicines) or, less often, ketamine. A 2024 review questioned this approach, noting that clear evidence of added benefit beyond lowering glycine has not been shown, so whether to use one is a decision to weigh with the metabolic team. Seizure medicines are chosen carefully. Valproate should be avoided because it raises glycine and may increase seizures, and vigabatrin has caused rapid loss of skills in some children. When seizures continue, a ketogenic diet (a very high-fat, low-carbohydrate eating plan) may help control them, based on small studies. Most children also need a wider team: neurology, a metabolic specialist and dietitian, feeding support for swallowing and reflux problems, developmental therapies, and orthopedic care. For children with severe NKH, pediatric palliative care can help families focus on comfort, fewer hospital stays and support at home.
The outlook depends greatly on the form. Many babies with severe NKH die in the newborn period or early infancy, often from breathing problems, and those who survive usually have profound intellectual disability, difficult seizures, muscle stiffness and feeding difficulties. Most do not reach milestones such as sitting up or grasping objects and need full-time care. Families often face decisions about breathing support, feeding and goals of care early on. Children with attenuated NKH reach developmental milestones, though at a slower pace and with a wide range of abilities. Many eventually walk and interact with others, sometimes communicating with sign language. Some have hyperactivity, involuntary jerking movements or muscle stiffness, and seizures, when present, are usually controllable. Ongoing care involves regular developmental and neurological checks, glycine and medicine monitoring, and attention to problems that commonly develop over time, including curvature of the spine (scoliosis), hip problems, reflux and repeated chest infections. Genetic counseling helps parents understand the chance of NKH in future pregnancies and the testing options available.
Ask for an evaluation by a metabolic or genetics specialist if a baby or young child has unexplained low muscle tone, seizures or slow development, especially when a sibling has NKH. Contact the care team promptly if a child with NKH has more frequent or different seizures, becomes unusually sleepy, has trouble feeding or keeping medicines down, or shows signs of a chest infection. A newborn who becomes harder and harder to wake or has pauses in breathing needs emergency care right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Nonketotic Hyperglycinemia is like, what's helped you, or ask the community a question.